Ginsenoside B2
- Generic Name
- Ginsenoside B2
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C48H82O18
- CAS Number
- 52286-59-6
- Unique Ingredient Identifier
- 46F3R0BL3I
- Background
Ginsenoside B2 is under investigation in clinical trial NCT00781534 (A Clinical Trial of Ginseng in Diabetes).
- Associated Conditions
- -
- Associated Therapies
- -
A Clinical Trial of Ginseng in Diabetes
Early Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-10-29
- Last Posted Date
- 2019-09-09
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 19
- Registration Number
- NCT00781534
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath